Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132225) titled 'Evaluation of the efficacy and safety of Edaravone Dexborneol in Acute Ischemic Stroke from Branch Atheromatous Disease: a multicenter, randomized, double-blind, placebo-controlled clinical study' on Sept. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First People's Hospital of Foshan
Condition:
Branch Atheromatous Disease
Intervention:
Experimental Group:Edaravone Dexborneol
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-18
Target Sample Size: Experimental Group:112;Control Group:112;
Countries of Recruitment:
China
To know more,...